secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001140361-25-001899
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics amends CEO and CFO employment agreements; enhances severance upon Change in Control
--------------------------------------------------------------------------------

- CEO Magrath severance multiple raised to 1.5x salary+target bonus on CIC termination; COBRA extended to 18 months.
- CFO Jhaveri severance multiple raised to 1.0x salary+target bonus; COBRA extended to 12 months.
- Magrath also gets prorated target bonus for non-CIC qualifying termination.
- Jhaveri's enhanced sever eligibility expanded to include 3 months prior to a Change in Control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125001899/0001140361-25-001899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125001899/ef20042243_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-001899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer